Amgen Inc
AMGN · NASDAQ342.00
342.00
USD4.101.21%날짜
티커
표제
원천
Amgen CEO says weight loss drug can address 'patient persistence issue'
CNBC
Amgen acquires Dark Blue Therapeutics for up to $840 million
SeekingAlpha
CEO of drugmaker Amgen talks new results from cholesterol drug trial
CNBC
🐾 Dogs of the Dow: Top 10 high-yield stocks for 2025 🐾 Ready to start 2025 with some high-yielding dividends? These Dogs of the Dow stocks are offering up to 6.8% yields! 📈 Here are the top 10 picks: - Verizon $VZ (6.79%) - Chevron $CVX (4.53%) - Amgen $AMGN (3.62%) -… https://t.co/DzcxZaFz5S https://t.co/QMeJT6CS7C
Amgen stock falls as analysts mull over weight loss drug’s bone density data
CNBC
🇺🇸EARNINGS THIS WEEK: • SUPER MICRO COMPUTER • PALANTIR • DATADOG • FORTINET • DISNEY • ELI LILLY • NOVO NORDISK • AMGEN • GILEAD SCIENCES • CVS HEALTH • CATERPILLAR • UBER • LYFT • SHOPIFY • ROBINHOOD • AIRBNB • WYNN • PARAMOUNT GLOBAL • TYSON FOODS •… https://t.co/5WNn7mAwCU https://t.co/K90g5rbCL8
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC
$AMGN | Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment Amgen reports quarterly earnings of $3.96 per share, which beat the analyst consensus estimate of $3.87 by 2.33%. The company reports quarterly sales of $7.447 billion, which beat the analyst… https://t.co/b5cDVUROQM https://t.co/KO1GM8SNRl
Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report
SeekingAlpha
Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
MarketWatch
Rep. James Comer probes FTC conduct in Amgen's takeover of Horizon Therapeutics
SeekingAlpha
Sen. Elizabeth Warren tells FTC she remains concerned about Amgen's Horizon deal
SeekingAlpha
Dow Jones Newswires: Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
MarketWatch
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
CNBC
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
MarketWatch
Amgen completes $27.8B acquisition of Horizon Therapeutics
SeekingAlpha
Amgen wins Irish approval for planned Horizon Therapeutics purchase
SeekingAlpha
Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen
SeekingAlpha
Catalyst Watch: Tesla deliveries, Google event, Kellogg spinoff, Amgen drama and Ether ETFs
Seeking Alpha
Amgen discloses more than $400 million stake in recent IPO Neumora Therapeutics
MarketWatch
Horizon Therapeutics ticks higher as Amgen end date extended until December
SeekingAlpha
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
CNBC
Irish High Court hearing for Horizon's $28B sale to Amgen set for Oct. 5
SeekingAlpha
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition
CNBC
Horizon Therapeutics gains amid reports FTC settled with Amgen over $28B deal
SeekingAlpha
Court hearing on FTC's challenge to Horizon/Amgen rescheduled until next week
SeekingAlpha
Amgen could reach settlement with FTC over Horizon in next few weeks - report
SeekingAlpha
Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks
SeekingAlpha
Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update)
SeekingAlpha
Horizon Therapeutics gains as FTC granted delay in-house trial on Amgen deal
SeekingAlpha
FTC likely to lose its challenge to the Horizon/Amgen deal, legal experts say - analyst
SeekingAlpha
Amgen says FTC case to block Horizon Therapeutics deal `defies logic'
SeekingAlpha
Horizon Therapeutics gains amid speculation on potential FTC settlement on Amgen
SeekingAlpha
Amgen says FTC has ignored commitments it made to address Horizon deal concerns
SeekingAlpha
Earnings Results: Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook
MarketWatch
Tepezza warning label unlikely to have any impact on Horizon/Amgen deal - analyst
SeekingAlpha
Amgen, FTC said there are no ongoing talks, though open to settlement over Horizon
SeekingAlpha
FTC said to have filed suit with ALJ on Horizon/Amgen deal (update)
SeekingAlpha
Amgen had settlement talks FTC over Horizon, though no agreement - report
SeekingAlpha
Six states join FTC lawsuit to block Amgen's planned purchase of Horizon
SeekingAlpha
Amgen sees potential for Horizon to close by mid-December under court schedule
SeekingAlpha
Bayer, Amgen looked at Iveric before agreeing to Astellas sale - report
SeekingAlpha
FTC's suit to block Amgen's purchase of Horizon Therapeutics set for Sept. 11 trial
SeekingAlpha
